Please CLICK HERE for the Basic Science Workshop Slides.
Please CLICK HERE for the Public Health Workshop Slides.
Please CLICK HERE for the Clinical Workshop Slides.
Please CLICK HERE for the Joint Public Health/Clinical Workshop Slides.
Public Health/ clinical
Tuesday, February 28, 2017
Public Health Workshop/Clinical Workshop Joint SessionGLOBAL UPDATE ON HPV EPIDEMIOLOGYChairs:
Cindy Firnhaber,
South Africa Jennifer Moodley,
South Africa
09:00 – Welcome
Cindy Firnhaber,
South Africa09:05 - Introduction to workshops
Jennifer Moodley,
South Africa09:15 - Comparing HPV burden between low, middle and high income countries
Silvia Franceschi, France09:40 - Macro-phenomena of HPV epidemiology in low, middle and high income countries
Lynette Denny,
South Africa 10:05 - Natural history of HPV infection and the impact of social determinants
Laia Alemany,
Spain
10:30 -
Coffee Break
Chairs: Hennie Botha, South Africa
Carla Chibwesha, South Africa
11:00 - The complex interplay between the two viruses
Anna-Lise Williamson,
South Africa
11:20 - HPV vaccine in HIV positive patients: update and influence on vaccination
programs
Adriana Weinberg,
USA
11:40 - The effect of HIV infection on cervical cancer screening policies, programmes and
their implementation
Carla Chibwesha, South Africa
12:00 - Non-cervical HPV related disease in HIV positive patients: update and considerations
for screening programs
Tim Wilkin,
USA
12:20 - HPV related disease in HIV positive patients: treatment challenges and implications
for treatment programs
Hennie Botha, South Africa
12:40 - The effect of anti-retroviral therapy and CD4 count on HPV related disease
Cindy Firnhaber, South Africa
13:00 -
Lunch Break
Public Health Workshop IMPLEMENTING AN HPV VACCINATION PROGRAMME Chairs:
Julia ML Brotherton,
Australia Edina Sinanovic, South Africa 14:00 - HPV vaccine update (age, number of doses, males) F. Xavier Bosch,
Spain 14:30 – Discussion F. Xavier Bosch, Spain Eduardo Franco,
Canada 14:45 - HPV vaccine introduction Guidance on use of cost- effectiveness models Edina Sinanovic, South Africa 15:15 – Discussion Julia ML Brotherton, Australia Edina Sinanovic, South Africa | Clinical Workshop CERVICAL CANCER SCREENING Chairs:
Greta Dreyer,
South Africa
Mark Einstein,
USA 14:00 - Cervical Cancer screening: global
overview Susan Cu-Uvin,
USA 14:30 – Discussion Susan Cu-Uvin, USA Mark Einstein, USA 14:45 - Obstacles to implementing HPV
primary screening
Hugo De Vuyst, France 15:15 – Discussion Greta Dreyer, South Africa Hugo De Vuyst, France |
15:30 -
Coffee Break
Public Health Workshop IMPLEMENTING AN HPV VACCINATION PROGRAMME (continued) Chairs: Eduardo Franco, Canada
Marc Steben,
Canada 14:45 - HPV vaccine introduction 16:00 - Implementation of HPV vaccination: Key lessons from across the globe: South Africa
Nonhlanhla Dlamini,
South Africa 16:10 - Implementation of HPV vaccination: Key lessons from across the globe: Australia
Julia ML Brotherton, Australia 16:20 - Implementation of HPV vaccination: Key lessons from across the globe: Malaysia
TBA 16:30 - Vaccine confidence: anticipating,
monitoring and taming anti-vaccine messages
TBA 16:45 - Monitoring and evaluation of HPV vaccine programmes
Gary Clifford,
France 17:15 – Discussion Gary Clifford, France Marc Steben, Canada |
Clinical Workshop CERVICAL CANCER SCREENING (continued) Chairs:
Elizabeth Stier,
USA
Marc Arbyn,
Belgium 16:00 - New thoughts on screen-and-treat
Rolando Herrero,
France 16:30 – Discussion Rolando Herrero, France
Marc Arbyn, Belgium 16:45 - Update on self-sampling
Jose Jeronimo,
USA 17:15 – Discussion Jose Jeronimo, USA Elizabeth Stier, USA |
Wednesday, March 1, 2017
Public Health Workshop IMPLEMENTING A CERVICAL SCREENING PROGRAMME Chairs: Raul Murrilo, Colombia TBA 09:00 - Panel discussion: Challenges and opportunities in implementing cervical cancer screening Jennifer Moodley, South Africa
TBA 09:20 - Screening: recruitment, communication and retention strategies Raul Murrilo, Colombia 09:40 - Engaging with the media
Adele Baleta, South Africa 10:00 - Future of cervical cancer screening in the post-vaccination era Eduardo Franco, Canada 10:20 – Discussion Raul Murrilo, Colombia TBA | Clinical Workshop HPV DISEASE TREATMENT CHOICES Chairs: Rengaswamy Sankaranarayan,
France
Nelly Mugo,
Kenya 09:00 - Minimal requirements for treatment
facilities Z Mike Chirenje, Zimbabwe 09:20 - LEEP/LLETZ: how, where and when
Greta Dreyer,
South Africa 09:40 - Local destruction techniques for cervical disease Rengaswamy Sankaranarayan, France 10:00 - Treatment for other gynecological HPV-related diseases Elizabeth Stier, USA 10:20 – Discussion Rengaswamy Sankaranarayan, France Nelly Mugo, Kenya |
10:30 -
Coffee Break
Public Health Workshop/Clinical Workshop Joint Session
WAY FORWARD
Chairs:
Anna-Lise Williamson,
South Africa
Silvia de Sanjose,
Spain
11:00 - Global imbalance of disease
Helen Rees,
South Africa
11:20 - Optimal management of HPV risk in HIV positive men and women
Joel Palefsky,
USA
11:40 - HPV related disease: Remaining research questions (Panel discussion)
Lynette Denny, South Africa
Anna-Lise Williamson, South Africa
Marc Steben, Canada
Eduardo Franco, Canada
12:10 - Moving from UN Millennium goals to UN Sustainable development goals: How can
we move from goals to eradication of cervical cancer
Silvia de Sanjose, Spain
basic science
Tuesday, February 28, 2017
- Virus Entry/Life Cycle
Renske Steenbergen,
The Netherlands
Michelle Ozbun,
USA - Carcinogenesis/Pathogenesis
Nicholas Wallace,
USA
Karl Munger, USA - Target Identification for Antiviral Drugs
Dohun Pyeon,
USA
Massimo Tommasino, France - Immune Response/Immune Escape
TBA
Margaret Stanely,
UK
Wednesday, March 1, 2017
- Basics of HPV Biology and Pathogenesis
Chair:
Alison McBride,
USA - Phylogenetic relationships of papillomaviruses
Robert Burk,
USA - Genome Structure, replication, transcription
Alison McBride, USA
- Viral life cycle
John Doorbar,
UK - Mechanism of carcinogenesis
TBA
- Basics of HPV Immunology and Vaccines
Chair:
John Schiller,
USA
- Assays for Infection and Immunity
Michael Pawlita, Germany - Immune response to Infection
Denise Galloway,
USA - Prophylactic vaccines
John Schiller, USA
- Immunotherapy
TBA